Innovating Works

BREAKthrough

Financiado
AICURIS ANTI-INFECTIVE CURES
N.D. | Participante
accelCH
N.D. | Participante
CNRS
282.69K€ | Participante
Syngulon
N.D. | Participante
UL
242.18K€ | Participante
NAICONS SRL
259.44K€ | Participante
URV
N.D. | Participante
ABAC THERAPEUTICS
251.97K€ | Participante
THE UNIVERSITY OF QUEENSLAND
N.D. | Participante
STICHTING VU
274.37K€ | Participante
MC
N.D. | Participante
UNEW
N.D. | Participante
F. HoffmannLa Roche AG
N.D. | Participante
STICHTING AMSTERDAM UMC
274.37K€ | Participante
UMIL
518.88K€ | Participante